首页> 外文期刊>The Journal of Urology >Re: Small prostate size and high grade disease--biology or artifact?: J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley and J. C. Presti, Jr. J Urol 2011; 185: 2108-2111.
【24h】

Re: Small prostate size and high grade disease--biology or artifact?: J. J. Liu, J. D. Brooks, M. Ferrari, R. Nolley and J. C. Presti, Jr. J Urol 2011; 185: 2108-2111.

机译:回复:小前列腺和高等级疾病-生物学还是假象?:J。J. Liu,J。D. Brooks,M。Ferrari,R。Nolley和J. C. Presti,Jr。J Urol,2011; 185:2108-2111。

获取原文
获取原文并翻译 | 示例
           

摘要

I read this article with great interest. The authors determined that small prostate size itself may not be a predictor of high grade disease, but rather the association between small prostate size and high grade disease may be a consequence of the performance characteristics of prostate specific antigen (PSA).I have some points of concern with this study. First, the authors classified the cases as Tic and T2. Median prostate weight was determined in each group. If the hypothesis is that prostate size predicts high grade prostate cancer, the cases must be classified according to prostate volume (PV). If cases with other pathological stages were added to the study, it could be more objective.Another point is the prognostic parameters of radical prostatectomy (RP) specimens.
机译:我非常感兴趣地阅读了这篇文章。作者确定,前列腺小号本身可能不是高级别疾病的预测指标,但前列腺小号与高级疾病之间的关联可能是前列腺特异抗原(PSA)的性能特征的结果。这项研究值得关注。首先,作者将病例分类为Tic和T2。在每组中确定前列腺中位数。如果假设是前列腺癌的大小预示着高级别的前列腺癌,则必须根据前列腺癌的体积(PV)对病例进行分类。如果将其他病理阶段的病例加入研究,则可能更客观。另一个要点是根治性前列腺切除术(RP)标本的预后参数。

著录项

相似文献

  • 外文文献
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号